Brief: Xspray Pharma To Await Result Of Two Ongoing Clinical Studies Before Submitting Its ANDA Application

Xspray Pharma publ AB

11/12/2020 12:12

Dec 11 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY PHARMA HAS DECIDED TO AWAIT THE RESULT OF TWO
ONGOING
CLINICAL STUDIES BEFORE SUBMITTING ITS ANDA APPLICATION
    * OBTAINED PRELIMINARY POSITIVE DATA FROM A STUDY ON
IMPROVED
HYNAP-DASA
    * MADE STRATEGIC DECISION TO SUBMIT ITS ANDA APPLICATION FOR
HYNAP-DASA IN EARLY 2021
    * DECISION ALLOWS XSPRAY PHARMA TO OPTIMIZE ITS STRATEGIC
COMMERCIAL OPPORTUNITIES FOR HYNAP-DASA PRODUCT PORTFOLIO

Source text for Eikon:  ID:nMFNbJw5RQ 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))